Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow PRECISION BIOSCIENCES INC

Get SEC filing alerts via email and in your feed for PRECISION BIOSCIENCES INC

DTIL

PRECISION BIOSCIENCES INC

About PRECISION BIOSCIENCES INC

Precision BioSciences is a clinical-stage biotechnology company specializing in in vivo gene editing therapies using its proprietary ARCUS platform. The platform employs engineered nucleases derived from natural homing endonucleases to develop precise, safe, and durable genetic treatments. The company focuses on therapies for infectious and genetic diseases, leveraging its innovative technology to create targeted, potentially curative solutions across multiple tissue types and conditions.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from PRECISION BIOSCIENCES INC

1
1
PRECISION BIOSCIENCES INC Precision BioSciences Reports $10.8 Million Revenue in Q1 2026 Amid Ongoing Losses

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
PRECISION BIOSCIENCES INC Precision BioSciences Reports $34.3M Revenue Decline and $45.7M Net Loss in 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
PRECISION BIOSCIENCES INC Precision BioSciences Reports $21.8 Million Net Loss and Revenue Decline in Latest Quarter

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
PRECISION BIOSCIENCES INC Precision BioSciences Reports Revenue Decline and Increased Operating Losses in Latest Quarter

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
PRECISION BIOSCIENCES INC Precision BioSciences Reports Significant Revenue Decline and Increased Losses in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
PRECISION BIOSCIENCES INC Precision BioSciences Reports $7.17 Million Net Income for 2024, Significant Revenue Growth

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
PRECISION BIOSCIENCES INC Precision BioSciences Reports Mixed Financial Results, Shifts Focus to Complex Gene Editing Programs

Via official filing (AI summary) | over 1 year ago | 0 comments